← Leaderboards
Olga Yarychkivska
Rockefeller University
$458,104
Attributed
$458,104
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $125K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$458,104 · 2
By mechanism
K99$249,998 · 1
F32$208,106 · 1
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- Shai Shaham$24,698,667
- Ali H Brivanlou$17,618,235
- Scott Thomas Forth$1,305,749
- Tarun M Kapoor$20,421,182
- Gregory M Alushin$4,214,310
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationMaleGenesInfarctionInvertebratesAutomobile DrivingCell TypeExhibitsGeneticHuntington DiseaseBiological ModelsApoptoticCaenorhabditis ElegansCaspaseCell CountAdultEventCell DeathApoptosisCessation Of LifeHuman DiseaseClinically SignificantCellsMalignant Neoplasms
Grant awards (5)
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals$124,999
K99 · FY2024 · GM · contact PI
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals$124,999
K99 · FY2023 · GM · contact PI
The molecular mechanism of LCD, a prevalent and conserved non-apoptotic cell death program$74,234
F32 · FY2022 · GM · contact PI
The molecular mechanism of LCD, a prevalent and conserved non-apoptotic cell death program$68,562
F32 · FY2021 · GM · contact PI
The molecular mechanism of LCD, a prevalent and conserved non-apoptotic cell death program$65,310
F32 · FY2020 · GM · contact PI